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Letters to the Editor 
Dear Editor 
Pneumothorax resulting from bronchial brushing during 
fibre-optic bronchoscopy 
Fibre-optic bronchoscopy (FOB) is a generally 
well tolerated procedure with a low incidence of com- 
plications. Bronchial brushings to obtain cytological 
specimens during FOB is a useful test in the diagnosis 
of bronchial carcinoma, either as an adjunct to 
bronchial or transbronchial biopsy, or in cases where 
biopsy is not safe or not possible. It is regarded as a safe 
procedure adding little extra risk to the bronchoscopy. 
Pneumothorax, when it occurs during FOB, tends to 
be related to transbronchial biopsy, although it has 
been reported following bronchoalveolar lavage (1). 
We report the case of a man who developed a 
pneumothorax during FOB as a result of bronchial 
brushings being performed. 
A 50-year-old male smoker was referred to the Chest 
Clinic with haemoptysis and recurrent cough. Chest 
radiograph showed a left hilum suspicious of an under- 
lying central bronchial neoplasm and he was therefore 
referred for FOB. No endobronchial lesion was seen, 
therefore a cytology brush was passed into the anterior 
and apicoposterior segments of the left upper lobe to 
obtain specimens. During the procedure he com- 
plained of left-sided chest pain. Clinical examination 
showed him to have reduced breath sounds on the left 
side and a subsequent chest radiograph demonstrated 
a 40% left-sided pneumothorax. The lung re- 
expanded satisfactorily following intercostal needle 
aspiration and he was discharged home the following 
day. Cytology from the brushings was benign and the 
radiological hilar abnormality proved to be a vascular 
shadow following a computerized axial tomography 
scan. 
Most chest physicians only perform chest radio- 
graphs following FOB if a transbronchial biopsy has 
been taken. Studies have suggested that routinely 
performing a chest radiograph following FOB is un- 
necessary if a pneumothorax is not clinically suspected 
and that this merely adds to the cost of the procedure 
(2,3). However, the clinical signs of pneumothorax 
are notoriously unreliable and, although chest pain is 
not an uncommon complaint following FOB, the 
consequences of missing a pneumothorax are poten- 
tially serious if tension ensues. Pneumothorax may 
therefore complicate FOB even if biopsies have not 
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been taken and, although we do not advocate a routine 
chest radiograph in all patients following FOB, we 
would suggest that a chest radiograph be obtained in 
those patients who complain of chest pain during or 
after this procedure. 
R.P. SMITH AND B.J. LIPWORTH 
Department of Respiratory Medicine, 
King’s Cross Hospital, 
Dundee, U.K. 
5 July 1991 
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Dear Editor 
Early management of community-acquired asthma 
We read with interest the paper by Drs Tang and 
Macfarlane (1) concerning fatal cases of community- 
acquired pneumonia (CAP). Like several previous 
audits of pneumonia, their study found that there was 
a delay of greater than 4 h prior to the administration 
of antibiotics to patients with severe pneumonia. 
Our experience in Salford is similar (2). We have 
reported a mean delay of 6.9 h from arrival in hospital 
to first antibiotic treatment in unselected cases of 
community-acquired pneumonia (12 h for oral treat- 
ment; 3.2 h for i.v. treatment). After this audit, we 
instituted hospital-wide guidelines for the manage- 
ment of CAP. These guidelines specified that the first 
dose of antibiotic should be given intravenously by the 
admitting doctor. Re-audit 1 year later showed a 62% 
reduction (to 2.6 h) in ‘door to treatment’ time. In 
the 22 cases where i.v. treatment was given, the mean 
time to treatment was only 2.2 h. This may be the best 
achievable average figure in view of the need for 
medical assessment and chest radiograph prior to 
treatment in most cases. 
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We therefore agree with Drs Tang and Macfarlane 
that hospital guidelines can be successful in improving 
pneumonia management. They are also popular with 
the junior medical staff 63% of whom reported fre- 
quent use of the pneumonia guidelines. We strongly 
recommend that the first dose of antibiotic should be 
given parenterally by the admitting doctor as a first 
oral dose is frequently delayed and might not be well 
absorbed by an ill patient. 
R. O'DRISCOLLANDD.DENNING 
Hope Hospital, 
Salford M6 8HD, U.K. 
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Dear Editor 
Management of allergic broncbopulmonary 
aspergillosis 
In his recent letter on this topic (1) Professor 
Anthony Seaton mentioned that he hoped shortly to 
publish details of his lengthy experience with allergic 
bronchopulmonary aspergillosis (ABPA), and I look 
forward with interest to reading his article or mono- 
graph. In the meantime, however, I would welcome his 
comments on views I have held for many years on the 
pathology and pathogenesis of that condition. Most 
writers on the subject, including Professor Seaton 
himself, seem to assume that the characteristic tran- 
sient radiographic opacities invariably represent 
inflammatory pulmonary exudates, as is indeed im- 
plied by their use in that context of the terms ‘infiltrate’ 
and ‘pneumonitis’. That may be so in some cases, but 
histological evidence in support of such a hypothesis is 
seldom if ever available, probably because lung biopsy 
is not often justified in what is essentially a benign 
condition. 
It has been recognized for many years (2) that in 
proven cases of ABPA bronchoscopically visible 
mucous plugs or casts, containing large numbers of 
fungal hyphae, may obstruct lobar or segmental 
bronchi and produce collapse of the related lobe or 
segment. It seems highly improbable that this cast for- 
mation is confined to the larger bronchi, and it could 
be postulated with a fair measure of confidence that 
multiple obstruction of more peripheral bronchi might 
be responsible for the anatomically less well-defined 
opacities observed in the majority of cases. Broncho- 
scopic extraction of plugs from lobar or segmental 
bronchi is invariably followed by re-expansion of the 
lobe or segment, and although plugs in smaller bronchi 
cannot be removed in that way, relief of asthmatic 
airways obstruction by an oral corticosteroid is often 
followed by the expectoration of numerous small plugs 
and casts, a phenomenon which lends credence to the 
hypothesis that many, if not most, of the radiographic 
opacities in ABPA, at least in the earlier episodes of 
that disease, are caused not by ‘pneumonitis’ but by 
bronchial obstruction. 
If bronchi, central or peripheral, remain obstructed 
for any length of time, secondary bacterial infection 
develops in the lung tissue they supply, and the end 
result in patients whose asthmatic airways obstruction 
has been inadequately controlled over a period of 
years (once common, but now less frequent) is 
bronchiectasis (distal, not proximal) and widespread 
pulmonary fibrosis. Proximal bronchiectasis, con- 
trary to popular belief, is a much less common com- 
plication of ABPA. It is presumably the result of 
plugs of mucus in large bronchi, heavily infiltrated by 
fungal hyphae, destructively expanding the bronchial 
wall. In such cases tomography may show branching 
lumpy shadows in the hilar region similar in outline 
to that of the dilated proximal bronchi seen on 
bronchography (2). 
How then can these pragmatic views on the pathol- 
ogy and pathogenesis of ABPA be reconciled with 
Professor Seaton’s erudite observations (3) on the 
immunopathogenesis of the disease? The two, I 
believe, are not incompatible if, as I suspect, the pri- 
mary immunological target is the bronchial wall and 
not lung tissue. Too little attention may, however, 
have been paid to the effect of airflow stasis, to coin a 
phrase, on the growth of A. fumigatus in inspissated 
bronchial mucus. The relief of airways obstruction by 
corticosteroids results in the release of mucous plugs 
and the fungal hyphae they contain, with a corres- 
ponding reduction in antigenic stimulation. In other 
words, if asthmatic airways obstruction is adequately 
treated ABPA will be controlled. In an acute situation 
where pulmonary opacities are present and asthmatic 
symptoms are severe oral steroids will be required for 
7-10 days, but thereafter inhaled steroids in appropri- 
ate dosage will usually be adequate to prevent further 
episodes, as reported by Balter and Rebuck (4). As 
Professor Seaton has pointed out, treatment with 
antifungal agents is seldom, if ever, necessary in the 
management of ABPA. 
We can at present only speculate as to whether 
asthma in ABPA is itself a manifestation of hyper- 
sensitivity to A. fumigatus antigens, or whether 
